Non-Allergic Rhinitis

Also known as: Non-allergic Rhinitis

DrugDrug NameDrug Description
DB00332IpratropiumIpratropium is a quaternary ammonium derivative of [atropine][A176957] that acts as an anticholinergic agent.[A176939] It is commonly administered through inhalation which allows producing a local effect without presenting a significant systemic absorption.[A176957] Ipratropium as a therapeutic agent was developed by Boehringer Ingelheim and its first monotherapy product was FDA approved in 1986.[L5891] On the other hand, the combination product of ipratropium and [albuterol] was approved in 1996.[L5894]
DrugDrug NamePhaseStatusCount
DB11883SB-7054982Completed2
DB06774Capsaicin4Recruiting1